| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |